PDGFRB and neoplasm: The switch in immunophenotype and the hyperactivated oncogenic signaling including the PDGFRB-STAT5-IL10 oncogenic axis might suggest epigenetic reprogramming of ALK+ tumor cells upon loss of HDAC1.